Association of hyperhomocysteinemia with left ventricular dilatation and mass in human heart

Peter Alter1, Heinz Rupp, Marga B Rominger

  • 1Internal Medicine-Cardiology, Philipps University, Marburg, Germany. alter@staff.uni-marburg.de

Insights

High homocysteine levels are linked to enlarged left ventricles (LV) in dilated cardiomyopathy. This suggests hyperhomocysteinemia contributes to LV dilatation and hypertrophy, potentially through oxidative stress.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Imaging

Background:

  • Hyperhomocysteinemia is a known risk factor for ischemic heart disease.
  • Mechanisms linking hyperhomocysteinemia to non-ischemic heart failure, specifically dilated cardiomyopathy, are being explored.
  • This study investigates the association between elevated homocysteine levels and left ventricular (LV) changes in dilated cardiomyopathy.

Purpose of the Study:

  • To determine if hyperhomocysteinemia is associated with left ventricular (LV) dilatation and hypertrophy in patients with dilated cardiomyopathy.
  • To explore the relationship between homocysteine levels and cardiac structural and functional parameters.

Main Methods:

  • Homocysteine levels were measured in 66 individuals with suspected cardiomyopathy.
  • Cardiac magnetic resonance imaging (CMR) was utilized to assess LV volume, mass, and wall stress.
  • Patients were categorized based on homocysteine levels and compared for cardiac parameters.

Main Results:

  • Hyperhomocysteinemia ( > 12 micromol/L) was prevalent in 68% of patients.
  • Patients with hyperhomocysteinemia exhibited significantly greater LV mass compared to those with normal homocysteine levels (83 vs. 67 g/m²).
  • Elevated homocysteine correlated with increased LV mass, LV end-diastolic volume (LVEDV), and LV end-systolic volume (LVESV), and LV dilatation was more common in patients with hyperhomocysteinemia.

Conclusions:

  • Hyperhomocysteinemia is implicated in disproportionate LV dilatation in dilated cardiomyopathy.
  • The observed hypertrophy may not adequately compensate for increased wall stress.
  • Increased oxidative stress due to hyperhomocysteinemia could be a mechanism contributing to muscle fiber changes and LV remodeling.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...